ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 128 filers reported holding ANTARES PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,019,000 | +17.6% | 736,241 | +2.4% | 0.00% | – |
| Q4 2021 | $2,567,000 | +18.4% | 719,090 | +20.7% | 0.00% | – |
| Q3 2021 | $2,168,000 | -12.9% | 595,828 | +4.3% | 0.00% | – |
| Q2 2021 | $2,490,000 | -10.5% | 571,041 | -15.6% | 0.00% | -100.0% |
| Q1 2021 | $2,781,000 | +0.8% | 676,705 | -2.1% | 0.00% | 0.0% |
| Q4 2020 | $2,759,000 | +57.9% | 691,333 | +6.9% | 0.00% | – |
| Q3 2020 | $1,747,000 | -2.0% | 646,924 | -0.2% | 0.00% | – |
| Q2 2020 | $1,783,000 | +20.1% | 648,545 | +3.0% | 0.00% | – |
| Q1 2020 | $1,485,000 | -60.8% | 629,369 | -21.9% | 0.00% | -100.0% |
| Q4 2019 | $3,789,000 | +80.4% | 806,219 | +28.4% | 0.00% | 0.0% |
| Q3 2019 | $2,100,000 | -0.0% | 627,865 | -1.7% | 0.00% | 0.0% |
| Q2 2019 | $2,101,000 | +11.8% | 638,603 | +2.9% | 0.00% | 0.0% |
| Q1 2019 | $1,880,000 | +8.5% | 620,492 | -2.6% | 0.00% | 0.0% |
| Q4 2018 | $1,733,000 | +3.5% | 636,911 | +27.9% | 0.00% | – |
| Q3 2018 | $1,674,000 | +25.8% | 498,155 | -3.5% | 0.00% | – |
| Q2 2018 | $1,331,000 | +7.4% | 516,082 | -8.4% | 0.00% | – |
| Q1 2018 | $1,239,000 | +14.1% | 563,131 | +3.2% | 0.00% | – |
| Q4 2017 | $1,086,000 | -37.5% | 545,786 | +1.8% | 0.00% | – |
| Q3 2017 | $1,738,000 | +2.7% | 536,125 | +2.0% | 0.00% | – |
| Q2 2017 | $1,692,000 | +255.5% | 525,506 | +213.7% | 0.00% | – |
| Q1 2017 | $476,000 | +46.5% | 167,515 | +20.1% | 0.00% | – |
| Q4 2016 | $325,000 | +25.0% | 139,486 | -9.9% | 0.00% | – |
| Q3 2016 | $260,000 | +1.6% | 154,898 | -36.3% | 0.00% | – |
| Q2 2016 | $256,000 | -49.0% | 243,057 | -57.9% | 0.00% | – |
| Q1 2016 | $502,000 | -27.7% | 577,273 | +0.6% | 0.00% | – |
| Q4 2015 | $694,000 | -49.9% | 574,053 | -29.6% | 0.00% | – |
| Q3 2015 | $1,386,000 | -19.8% | 815,079 | -1.9% | 0.00% | – |
| Q2 2015 | $1,729,000 | -9.0% | 831,273 | +18.6% | 0.00% | – |
| Q1 2015 | $1,899,000 | +11.2% | 701,196 | +5.5% | 0.00% | – |
| Q4 2014 | $1,708,000 | +40.3% | 664,570 | -0.1% | 0.00% | – |
| Q3 2014 | $1,217,000 | -76.0% | 665,260 | -65.0% | 0.00% | -100.0% |
| Q2 2014 | $5,072,000 | +57.0% | 1,900,072 | +105.9% | 0.00% | 0.0% |
| Q1 2014 | $3,230,000 | -12.3% | 922,742 | +12.0% | 0.00% | 0.0% |
| Q4 2013 | $3,682,000 | -38.2% | 823,763 | -43.9% | 0.00% | 0.0% |
| Q3 2013 | $5,960,000 | +123.6% | 1,467,306 | +129.0% | 0.00% | 0.0% |
| Q2 2013 | $2,666,000 | – | 640,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 1,820,524 | $4,697,000 | 3.00% |
| ARMISTICE CAPITAL, LLC | 12,050,000 | $31,089,000 | 2.03% |
| Broadfin Capital, LLC | 4,623,247 | $11,928,000 | 1.88% |
| Healthcare Value Capital, LLC | 100,000 | $258,000 | 0.73% |
| Healthcare Value Capital, LLC | 100,000 | $258,000 | 0.73% |
| MYCIO WEALTH PARTNERS, LLC | 2,433,500 | $6,278,000 | 0.65% |
| PERKINS CAPITAL MANAGEMENT INC | 317,500 | $819,000 | 0.59% |
| Brown Advisory Securities, LLC | 275,000 | $710,000 | 0.12% |
| FALCON POINT CAPITAL, LLC | 222,501 | $574,000 | 0.11% |
| Avenir Corp | 291,597 | $752,000 | 0.09% |